Helen Hill, Elena Mitsi, Elissavet Nikolaou, Annie Blizard, Sherin Pojar, Ashleigh Howard, Angela Hyder-Wright, Jack Devin, Jesus Reiné, Ryan Robinson, Carla Solórzano, Simon P Jochems, Tinashe Kenny-Nyazika, Elisa Ramos-Sevillano, Caroline M Weight, Chris Myerscough, Daniella McLenaghan, Ben Morton, Emily Gibbons, Madlen Farrar, Victoria Randles, Hassan Burhan, Tao Chen, Adam D Shandling, Joe J Campo, Robert S Heyderman, Stephen B Gordon, Jeremy S Brown, Andrea M Collins, Daniela M Ferreira
Rationale: Pneumococcal pneumonia remains a global health problem. Pneumococcal colonization increases local and systemic protective immunity, suggesting that nasal administration of live attenuated Streptococcus pneumoniae (Spn) strains could help prevent infections. Objectives: We used a controlled human infection model to investigate whether nasopharyngeal colonization with attenuated S. pneumoniae strains protected against recolonization with wild-type (WT) Spn (SpnWT). Methods: Healthy adults aged 18-50 years were randomized (1:1:1:1) for nasal administration twice (at a 2-wk interval) with saline solution, WT Spn6B (BHN418), or one of two genetically modified Spn6B strains, SpnA1 ( Δfhs/piaA ) or SpnA3 ( ΔproABC/piaA ) (Stage I)...
October 15, 2023: American Journal of Respiratory and Critical Care Medicine